Gene · 8239
Papers1,917
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,917
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications. | MedComm (2020) | 2023 | 37143582 | PubTator, text mining | PubMed |
| Systematics and phylogeography of bats of the genus Rhynchonycteris (Chiroptera: Emballonuridae): Integrating molecular phylogenetics, ecological niche modeling and morphometric data. | PLoS One | 2023 | 37141273 | PubTator, text mining | PubMed |
| Ubiquitin specific peptidase 37 and PCNA interaction promotes osteosarcoma pathogenesis by modulating replication fork progression. | J Transl Med | 2023 | 37118828 | PubTator, text mining | PubMed |
| Marine Polyether Phycotoxin Palytoxin Induces Apoptotic Cell Death via Mcl-1 and Bcl-2 Downregulation. | Mar Drugs | 2023 | 37103372 | PubTator, text mining | PubMed |
| Multi-omics analysis of the Indian ovarian cancer cohort revealed histotype-specific mutation and gene expression patterns. | Front Genet | 2023 | 37091785 | PubTator, text mining | PubMed |
| Non‑coding RNAs: Role of miRNAs and lncRNAs in the regulation of autophagy in hepatocellular carcinoma (Review). | Oncol Rep | 2023 | 37083063 | PubTator, text mining | PubMed |
| Structure-based discovery of potent USP28 inhibitors derived from Vismodegib. | Eur J Med Chem | 2023 | 37075624 | PubTator, text mining | PubMed |
| Novel Variant in the USP9X Gene Is Associated with Congenital Heart Disease in a Male Patient: A Case Report and Literature Review. | Mol Syndromol | 2023 | 37064340 | PubTator, text mining | PubMed |
| USP9X expression is functionally related to laryngeal cancer. | J Cancer | 2023 | 37057289 | PubTator, text mining | PubMed |
| Ubiquitin-proteasome system-mediated ubiquitination modification patterns and characterization of tumor microenvironment infiltration, stemness and cellular senescence in low-grade glioma. | Aging (Albany NY) | 2023 | 37053008 | PubTator, text mining | PubMed |
| Sex and Gender Differences in Neurodegenerative Diseases: Challenges for Therapeutic Opportunities. | Int J Mol Sci | 2023 | 37047320 | PubTator, text mining | PubMed |
| Specialized Ribosomes in Health and Disease. | Int J Mol Sci | 2023 | 37047306 | PubTator, text mining | PubMed |
| EGFR endocytosis: more than meets the eye. | Oncotarget | 2023 | 37036745 | PubTator, text mining | PubMed |
| USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable therapeutic vulnerabilities. | Cell Rep Med | 2023 | 37030295 | PubTator, text mining | PubMed |
| Comparison of Genetic Profiles of Neonates in Intensive Care Units Conceived With or Without Assisted Reproductive Technology. | JAMA Netw Open | 2023 | 37014641 | PubTator, text mining | PubMed |
| Effectors and effects of arginine methylation. | Biochem Soc Trans | 2023 | 37013969 | PubTator, text mining | PubMed |
| Exploiting E3 ubiquitin ligases to reeducate the tumor microenvironment for cancer therapy. | Exp Hematol Oncol | 2023 | 36998063 | PubTator, text mining | PubMed |
| KSHV Viral Protein Kinase Interacts with USP9X to Modulate the Viral Lifecycle. | J Virol | 2023 | 36995092 | PubTator, text mining | PubMed |
| Inhibition of ox-LDL-induced endothelial cell injury by LINC02381 knockdown through the microRNA-491-5p/transcription factor 7 axis. | Immun Inflamm Dis | 2023 | 36988257 | PubTator, text mining | PubMed |
| High Performance of a Dominant/X-Linked Gene Panel in Patients with Neurodevelopmental Disorders. | Genes (Basel) | 2023 | 36980980 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8239/papers?page=13